TrPR Program @ UCSF retweeted
Replying to @thebandlab @hubermanlab @UCSF @Stanford @RCarhartHarris @NolanRyWilliams @Drug_Researcher @JHPsychedelics @MAPS @tferriss @TrPR_Program
Great read @thebandlab! It is a remarkable time for the future of psychedelic medicines and we are proud to be part of the developments alongside a remarkable team.
TrPR Program @ UCSF retweeted
Replying to @hubermanlab @UCSF @Stanford @RCarhartHarris @NolanRyWilliams @Drug_Researcher @JHPsychedelics @MAPS @tferriss
We @TrPR_Program @ucsf agree that this is an exciting time for psychedelic research in the Bay! Here’s a link to the ucsf magazine article that describes our efforts @ucsf
Trip therapy: Could psychedelics become mainstream medicines?
Read for more about the future of psychedelic medicines: ucsfpsy.ch/3R5ALLQ
@thebandlab @RCarhartHarris
TrPR Program @ UCSF retweeted
Replying to @thebandlab @hubermanlab @UCSF @Stanford @RCarhartHarris @NolanRyWilliams @Drug_Researcher @JHPsychedelics @MAPS @tferriss @TrPR_Program
As we are talking about psychedelic research at @ucsf and @StanfordMed, would like to highlight our ongoing collaboration w/ @TheBorisLab on a trial of psilocybin for chronic low back pain starting recruitment shortly.
TrPR Program @ UCSF retweeted
I had a great time interviewing Dr. David Gard about psilocybin-assisted therapy, and how psychologists may be integrating such tools into future practice. He also shared some updates about the @TrPR_Program trial of 🍄 for depression in #bipolardisorder type 2. More 📽️ to come!
NEW EPISODE! #talkBD🍄
Researcher/psychologist Dr. David Gard breaks down the latest research on psychedelics in supporting mental health, use of psilocybin to treat #bipolar, and reviews the benefits and risks.
📺Stream on YouTube/all podcast platforms: talkBD.live/psilocybin
TrPR Program @ UCSF retweeted
Survey study on meds in individuals with an eating disorder, please share. redcap.sydney.edu.au/surveys…
TrPR Program @ UCSF retweeted
Nice to see @TrPR_Program work referenced in the NYT nytimes.com/2023/02/10/well/… risk of psychedelics causing mania/psychosis especially in people with personal or fam hx of bipolar is complex. If it occurs, the rates must be very low. We are conducting a trial in bd2 to learn more.
TrPR Program @ UCSF retweeted
Are you or someone you know currently depressed and have bipolar 2 disorder? @Trpr_program is recruiting for a trial of psilocybin therapy. To learn more, for to psychedelics.ucsf.edu or email [email protected].
TrPR Program @ UCSF retweeted
An international web-based survey on experiences of psilocybin consumption found that 32.2% of respondents w/ bipolar disorder described new/increasing symptoms after psilocybin trips.
ucsfpsy.ch/40tG5gu
TrPR Program @ UCSF retweeted
A privilege to move this work forward with @TrPR_Program!
The longer people with #anorexia go untreated, “the worse the chance of recovery is," UCSF's Dr. Amanda Downey (@drdowneydoes) says. Downey & team will be studying the impact of psychedelics on younger patients with the #EatingDisorder. ucsfh.org/3VT4l8h
TrPR Program @ UCSF retweeted
Looking for physicians interested in developing an academic career in psychedelic research! @TrPR_Program has fellowships for MD's/D.O.'s. All relevant specialties welcome. 2 yrs support w/ 3rd yr extension possible. Salary in line with PGY scale. DM w/ CV if interested!
TrPR Program @ UCSF retweeted
We are hiring multiple experienced clinical research coordinators to work on Phase 2 and 3 clinical trials of psychedelics. DM me for details.
TrPR Program @ UCSF retweeted
Silo Pharma and UCSF plan to study #psilocybin as an anti-inflammatory agent in Parkinson’s and Bipolar Patients. @TrPR_Program
bit.ly/3zkED2m
TrPR Program @ UCSF retweeted
Natural psychedelic drug discovery and extraction company Filament Health has today announced a collaboration with UCSF’s recently-launched TrPR Program.
psilocybinalpha.com/news/fil…
TrPR Program @ UCSF retweeted
Excellent discussion of the recent NEJM psilocybin trial. Discusses important issues around pre-registration, interpretation of non-significant results, recruitment and more. @TheBorisLab














